SC-26 The case of dolutegravir plus darunavir antiretroviral regimens: is it always useful to double the drug doses? is a research paper published in Short Communication (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Fields of Study
Keywords
Sustainable Development Goals